Journal
BIOMARKERS IN MEDICINE
Volume 13, Issue 17, Pages 1481-1491Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2019-0178
Keywords
biomarker; cancer; cervix; density; gastric; glioblastoma; lung; lymphocytes; macrophages; melanoma
Categories
Funding
- Programa Nacional de Innovacion para la Competitividad y Productividad-Innovate Peru [317-PNICP-EC-2014]
- CONCYTEC [197-2015-FONDECYT]
Ask authors/readers for more resources
Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune cell and clinicopathological features in different malignancies. Methods: 209 pathological samples from gastric cancer, cervical cancer (CC), non-small-lung cancer, cutaneous melanoma (CM) and glioblastoma were tested for TIL in hematoxylin eosin, and density of CD3(+), CD4(+), CD8(+), CD20(+), CD68(+) and CD163(+) cells by digital analysis. Results: TIL levels were higher in invasive margin compartments (IMC). TIL in IMC, intratumoral and stromal compartments predicted survival. CC and gastric cancer had higher TIL in intratumoral; CC and CM had higher TIL in stromal compartment and IMC. CM had the highest density of lymphocyte and macrophage populations. CD20 density was associated with survival in the whole series. Conclusion: Standardized evaluation of TIL levels may provide valuable prognostic information in a spectrum of different malignancies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available